Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The Association for Accessible Medicines spent over $1 million between January and July on healthcare and generics-related bills, including the Clear Labels Act.”
VerifiedConfidence: HIGH

Reasoning

The ProPublica article reports that the Association for Accessible Medicines (AAM) spent over $1 million between January and July on lobbying for healthcare and generics‑related legislation, specifically mentioning the Clear Labels Act. This matches the claim exactly.

On confidence: The claim is directly supported by a reputable investigative article that cites the Association for Accessible Medicines' public filings.

Important context

The evidence comes from ProPublica, a well‑established investigative news organization, which references AAM’s own public lobbying disclosures.

Evidence

Supporting (1)

Limitations

The verification relies on a single source; while ProPublica is credible, additional independent confirmation (e.g., directly from AAM’s filings) would further strengthen the finding.

Last verified:
Sep 27, 2026, 4:24 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote

ProPublica · Naisha Roy